Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027806 · ClinicalTrials.gov registry record · Phase 4
Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children
A Phase 4 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT01027806 is a Phase 4 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 64 participants.
The verdict
NCT01027806, a Phase 4 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
The investigators leading hypotheses are: * Oral therapy with montelukast may lead to improved sleep study findings in children with mild to moderate Obstructive Sleep Apnea Syndrome (OSAS) who require surgical removal of adenoids and tonsils for OSAS. * A significant proportion of the children with OSAS treated with montelukast will show reduced severity of OSAS, and this will remove the need for surgical intervention.
Interventions
- DRUG Montelukast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027806
The ClinicalTrials.gov registry entry for NCT01027806 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Montelukast is the first listed.
NCT01027806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027806 about?
NCT01027806 is a clinical study titled "Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children". The investigators leading hypotheses are: * Oral therapy with montelukast may lead to improved sleep study findings in children with mild to moderate Obstructive Sleep Apnea Syndrome (OSAS) who require surgical removal of adenoids and tonsils for OSAS. * A significant proportion of the children wit...
What is the current status of trial NCT01027806?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2010-07. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01027806?
The interventions under investigation include: Montelukast (DRUG).
Who is sponsoring clinical trial NCT01027806?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.